Dow Jones

38 589,16

-0,15%

DAX

Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Oasmia Pharmaceuticals AB (OASM)
Oasmia Pharmaceuticals AB (OASM) Actualités

OASM

Oasmia Pharmaceuticals AB (OASM)

Oasmia Pharmaceuticals AB

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:OASM

1 2 3 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
07/03/2022	14h35	Business Wire	CORRECTING and REPLACING Whiting and Oasis to Combine in $6.0 Billion Merger of Equals Transaction	NASDAQ:OASM	Oasmia Pharmaceuticals AB
07/03/2022	13h20	Business Wire	Whiting and Oasis to Combine in $6.0 Billion Merger of Equals Transaction	NASDAQ:OASM	Oasmia Pharmaceuticals AB
27/11/2019	15h54	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:OASM	Oasmia Pharmaceuticals AB
21/11/2019	15h41	Edgar (US Regulatory)	Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)	NASDAQ:OASM	Oasmia Pharmaceuticals AB
23/08/2019	14h01	Edgar (US Regulatory)	Notice of Termination of a Foreign Private Issuer's Registration of a Class of Securities Under Section 12(b) (15f-12b)	NASDAQ:OASM	Oasmia Pharmaceuticals AB
21/08/2019	22h06	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:OASM	Oasmia Pharmaceuticals AB
13/08/2019	12h03	Edgar (US Regulatory)	Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeeme...	NASDAQ:OASM	Oasmia Pharmaceuticals AB
13/08/2019	12h00	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:OASM	Oasmia Pharmaceuticals AB
08/08/2019	22h15	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:OASM	Oasmia Pharmaceuticals AB
20/11/2018	08h00	GlobeNewswire Inc.	New U.S. patent related to Oasmia Pharmaceutical’s nanotechnology platform XR17 has been granted	NASDAQ:OASM	Oasmia Pharmaceuticals AB
03/10/2018	09h00	GlobeNewswire Inc.	Oasmia Presents Positive Efficacy and Safety Data for Doxophos Vet in Treatment of Naïve Dogs with Lymphoma	NASDAQ:OASM	Oasmia Pharmaceuticals AB
21/09/2018	09h20	GlobeNewswire Inc.	Oasmia Pharmaceutical Receives Positive CHMP Opinion for Apealea® (paclitaxel micellar) in the European Union	NASDAQ:OASM	Oasmia Pharmaceuticals AB
14/09/2018	22h13	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:OASM	Oasmia Pharmaceuticals AB
31/08/2018	22h09	Edgar (US Regulatory)	Notification That Form 20-f Will Be Submitted Late (nt 20-f)	NASDAQ:OASM	Oasmia Pharmaceuticals AB
18/05/2018	22h09	Edgar (US Regulatory)	Securities Registration (foreign Private Issuer) (f-3/a)	NASDAQ:OASM	Oasmia Pharmaceuticals AB
30/04/2018	22h19	Edgar (US Regulatory)	Securities Registration (foreign Private Issuer) (f-3)	NASDAQ:OASM	Oasmia Pharmaceuticals AB
11/04/2018	22h07	Edgar (US Regulatory)	Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)	NASDAQ:OASM	Oasmia Pharmaceuticals AB
14/02/2018	15h41	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:OASM	Oasmia Pharmaceuticals AB
01/11/2017	20h24	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:OASM	Oasmia Pharmaceuticals AB
08/08/2017	13h00	GlobeNewswire Inc.	Oasmia Pharmaceutical receives market approval for its Anti-Cancer Drug Doxophos® in Russia	NASDAQ:OASM	Oasmia Pharmaceuticals AB
14/06/2017	13h00	GlobeNewswire Inc.	Oasmia Pharmaceutical enters into new exclusive marketing and distribution agreement concerning Russia and other CIS markets	NASDAQ:OASM	Oasmia Pharmaceuticals AB
13/02/2017	22h39	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:OASM	Oasmia Pharmaceuticals AB
23/01/2017	13h00	GlobeNewswire Inc.	Oasmia Pharmaceutical Announces Strategic Move to Bolster Efforts for its Veterinary Division	NASDAQ:OASM	Oasmia Pharmaceuticals AB
09/01/2017	21h22	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:OASM	Oasmia Pharmaceuticals AB
21/12/2016	13h00	GlobeNewswire Inc.	Oasmia Pharmaceutical Reports Positive Results from Study on Weekly Administration of Apealea® (Paclical®)	NASDAQ:OASM	Oasmia Pharmaceuticals AB
07/12/2016	15h30	GlobeNewswire Inc.	Oasmia Pharmaceutical AB’s Warrant Programs Fully Subscribed	NASDAQ:OASM	Oasmia Pharmaceuticals AB
02/12/2016	16h05	GlobeNewswire Inc.	Interim report for the period May - October 2016	NASDAQ:OASM	Oasmia Pharmaceuticals AB
22/11/2016	13h49	GlobeNewswire Inc.	Communiqué from Extraordinary General Meeting 2016	NASDAQ:OASM	Oasmia Pharmaceuticals AB
02/11/2016	12h24	GlobeNewswire Inc.	Nexttobe Extends Loan to Oasmia Pharmaceutical	NASDAQ:OASM	Oasmia Pharmaceuticals AB
01/11/2016	22h19	GlobeNewswire Inc.	Oasmia Pharmaceutical Announces Change in Ownership	NASDAQ:OASM	Oasmia Pharmaceuticals AB